Molecular Diagnostics
Blood Test Identifies Those at High Risk of Developing Human Tuberculosis
New research presented at ECCMID 2022 has shown that Actiphage, a new blood test for Mycobacterium tuberculosis (Mtb) can improve identification of those at risk of progressive tuberculosis infection, offering potential for a rapid, non-invasive biomarker for early screening of asymptomatic individuals. More...26 Apr 2022
RNA-Based Noninvasive Gut Tests Enable Early Colorectal Cancer Screening
A new diagnostic platform uses stool-derived eukaryotic RNA (seRNA) to detect colorectal cancer and precancerous adenomas. Unlike other noninvasive screening options that use DNA or blood-based biomarkers, the proprietary method from Geneoscopy Inc. (St. Louis, MO, USA) analyzes RNA extracted from patient stool samples to provide the phenotypic and quantitative information necessary to accurately detect precancerous lesions. More...25 Apr 2022
New BD Assay Speeds Discovery in Autoimmune Disorders, Immuno-Oncology, and Infectious Diseases
Becton, Dickinson and Company (BD Franklin Lakes, NJ, USA) has launched the BD Rhapsody TCR/BCR Multiomic Assay, an innovative set of reagents that enables researchers to more easily and comprehensively analyze important cells in the immune system, providing a tool to advance research in autoimmune disorders, immuno-oncology and infectious diseases. More...22 Apr 2022
Testing for Protein in Blood Receives More Support as Biomarker for Brain Disorders
Frontotemporal dementia (FTD) is a group of brain disorders characterized by changes in behavior, cognition, language or movement that has few treatment options. These disorders involve degeneration and shrinkage of the frontal and temporal lobes of the brain. Now, a test of protein in the blood has received further support as a biomarker for patients diagnosed with FTD. More...21 Apr 2022
Blood Test to Diagnose Skin Cancer May Help Avoid Invasive Skin Biopsies
Recent advances in liquid biopsy have proposed less-invasive alternatives for cancer diagnosis and monitoring using minimal invasion at sample collection, and circulating tumor cells (CTCs) have been considered a promising blood-based surrogate marker of primary tumors. Now, new research indicates that testing an individual’s blood can reveal the presence of CTCs. Such tests may allow patients to forego invasive skin biopsies to determine whether they have skin cancer. More...21 Apr 2022
Gold Member
Hybrid Pipette
SWITCH
Silver Member
PCR Plates
Diamond Shell PCR Plates
Gel Cards
DG Gel Cards
In Other News
Tumor Suppressor Adenomatous Polyposis Coli Regulates T Lymphocyte Migration
A Novel Small RNA Biomarker for Early Liver Cancer Diagnosis
NGS Technology-Based Assay Detects Minimal Residual Disease in Patients with Lymphatic Hematological Tumors
World’s First Rapid Oral Cancer Test to Revolutionize Diagnosis and Treatment
Broad Gene Panel Diagnoses Patients With Kidney Disease
Single-Cell RNA-Seq Reveals Cell Type–Specific Molecular and Genetic Associations to Lupus
Lyo-Ready PCR Reagents Make Ultra-Sensitive Diagnostics Development Painless
Smartphone-Powered Microfluidic ‘Lab on a Strip’ Dengue Test More Powerful Than LFT Testing
Single-Cell RNA Sequencing Identifies Mechanisms Underlying Autoimmune Diseases
Cervicovaginal DNA Virome Alterations Associated with Genital Inflammation
High-Throughput Screening Assay Identifies Drugs to Treat Resistant Prostate Cancer
Circulating Levels of Anti-Müllerian Hormone Can Identify Premenopausal Women Prior to Significant Bone Density Loss
POC Sepsis Diagnostic Platform to Speed up Clinical and Treatment Decision Making
AI-Powered Voice-Activated Pipettes Streamline Processes and Increase Lab Productivity
Liquid Biopsy Enables Early Cancer Detection in Li-Fraumeni Syndrome Patients
World-First Bedside Genetic Test Identifies Susceptibility to Deafness in Newborn Babies
World-First Bedside Genetic Test Identifies Susceptibility to Deafness in Newborn Babies
Blood Test to Detect Protein Biomarkers Identified Using Breast Milk Could Enable Breast Cancer Screening
Newly Identified Biomarkers Detect Subcortical Small-vessel Disease
miRNA-Based Blood Borne Diagnostic Test Holds Potential for Management of Cancer Patients
Liquid Biopsy Can Detect Recurrent Breast Cancer and Monitor Progression
Thermo Fisher Launches CE-IVD Marked NGS Instrument for Diagnostic Testing
Siemens sNfL Blood Test Predicts Risk of MS Disease Activity
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.